This website is intended for healthcare professionals only.
Hospital Pharmacy Europe
Newsletter
Login
News
In depth
Views
Clinical
Cardiovascular
Dermatology
Emergency and critical care
Gastroenterology
Oncology
Paediatrics
Pathology and diagnostics
Radiology and imaging
Respiratory
Rheumatology
Insight and Analysis
Q&As
European healthcare data
Webinars
Country profiles
Events
Sponsored
Newsletter
Hospital Pharmacy Europe
Clinical
Nusinersen approved in the EU as first treatment for spinal muscular atrophy
Read more
Biosimilar adalimumab and infliximab accepted for regulatory review by the EMA
Read more
NICE publishes recommendation for everolimus in final draft guidance
Read more
Hodgkin lymphoma survivors have more severe coronary artery disease post-chest irradiation
Read more
High mortality and financial burden for pulmonary disease due to non-tuberculosis mycobacterium
Read more
Supporting awareness of Viking disease
Read more
Treating paediatric short bowel syndrome
Read more
Nusinersen receives positive CHMP opinion for the treatment of spinal muscular atrophy
Read more
Use of extended-pulsed regimen with fidaxomicin more effective than standard vancomycin in CDI
Read more
NRAS launches video to help raise awareness of new developments in treatment
Read more
Proposed rituximab and etanercept biosimilars recommended for approval in Europe
Read more
Tagrisso receives full approval in the EU
Read more
AF patients say ‘yes’ to the freedom that self-monitoring gives them
Read more
NICE recommends Stelara for moderate to severe Crohn’s disease
Read more
CHMP positive opinion for sarilumab in moderate to severe rheumatoid arthritis
Read more
Norgine and ELPA continue to improve management of hepatic encephalopathy
Read more
New report reveals little progress on 2014 WHO psoriasis recommendations
Read more
Page 136 of 200
« First
«
...
10
20
30
...
134
135
136
137
138
...
150
160
170
...
»
Last »
Popular articles
New protocol for IBD referral triage reduces diagnostic delays, say researchers
24 April, 2024
Bimekizumab gains EC approval for hidradenitis suppurativa
22 April, 2024
Semaglutide shows promise in patients with type 2 diabetes and obesity-related heart failure
22 April, 2024
x
Search for: